secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2025-11-24T23:59:59+00:00
Accession:  0001437749-25-036076
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia appoints Farhan Shahab as VP of Quality
-------------------------------------------------

- Farhan Shahab named Vice President of Quality, effective November 24, 2025.
- Shahab brings over 25 years of experience in quality and regulatory roles at Medtronic, AngioScore, and Welldoc.
- CEO Peter Altman says Shahab's expertise will accelerate commercialization of investigational products.
- Shahab holds a BS in Chemical Engineering from UMass and an MBA from University of Phoenix.
- He is Regulatory Affairs Certified (RAC) and Certified Auditor (Exemplar Global).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774925036076/0001437749-25-036076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774925036076/bcda20251121_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-036076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer